Cargando…

Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach

BACKGROUND: Data monitoring of clinical trials is a tool aimed at reducing the risks of random errors (e.g. clerical errors) and systematic errors, which include misinterpretation, misunderstandings, and fabrication. Traditional ‘good clinical practice data monitoring’ with on-site monitors increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olsen, Markus Harboe, Hansen, Mathias Lühr, Safi, Sanam, Jakobsen, Janus Christian, Greisen, Gorm, Gluud, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325420/ https://www.ncbi.nlm.nih.gov/pubmed/34332547 http://dx.doi.org/10.1186/s12874-021-01344-4

Ejemplares similares

Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants
por: Olsen, Markus Harboe, et al.
Publicado: (2023)

Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III
por: Hansen, Mathias Lühr, et al.
Publicado: (2020)

The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial
por: Vestager, Maria Linander, et al.
Publicado: (2023)

Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial
por: Hansen, Mathias Lühr, et al.
Publicado: (2019)

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial
por: Rasmussen, Marie Isabel, et al.
Publicado: (2023)

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial
por: Plomgaard, Anne M., et al.
Publicado: (2017)

The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings
por: Riera, Joan, et al.
Publicado: (2016)

Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants
por: Hansen, Mathias Lühr, et al.
Publicado: (2019)

Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown
por: Rasmussen, Marie Isabel, et al.
Publicado: (2021)

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life
por: Plomgaard, Anne M., et al.
Publicado: (2018)

Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments
por: Plomgaard, Anne M, et al.
Publicado: (2016)

The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury
por: Plomgaard, Anne M., et al.
Publicado: (2016)

Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial
por: Plomgaard, Anne Mette, et al.
Publicado: (2022)

A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial
por: Hyttel-Sorensen, Simon, et al.
Publicado: (2013)

The clinical effects of cerebral near-infrared spectroscopy monitoring (NIRS) versus no monitoring: a protocol for a systematic review with meta-analysis and trial sequential analysis
por: Hansen, Mathias Lühr, et al.
Publicado: (2021)

Antibiotic regimens for neonatal sepsis - a protocol for a systematic review with meta-analysis
por: Korang, Steven Kwasi, et al.
Publicado: (2019)

Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
por: Sethi, Naqash J., et al.
Publicado: (2018)

The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis
por: Sethi, Naqash J., et al.
Publicado: (2017)

The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
por: Sethi, Naqash J., et al.
Publicado: (2017)

Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
por: Sethi, Naqash J., et al.
Publicado: (2017)

Behavioural and neurodevelopmental impairment at school age following necrotising enterocolitis in the newborn period
por: Hansen, Mathias Lühr, et al.
Publicado: (2019)

Early Orthostatic Exercise by Head-Up Tilt With Stepping vs. Standard Care After Severe Traumatic Brain Injury Is Feasible
por: Riberholt, Christian Gunge, et al.
Publicado: (2021)

Observed intervention effects for mortality in randomised clinical trials: a methodological study protocol
por: Hansen, Mathias Lühr, et al.
Publicado: (2023)

Assessment of BPH/BOO
por: Mangera, Altaf, et al.
Publicado: (2014)

Detailed statistical analysis plan for the neurological complications in endoscopic versus open radial artery harvest (NEO) randomised clinical trial
por: Carranza, Christian L., et al.
Publicado: (2022)

UV spectrum of $\lambda$ Boo
por: Gerbaldi, M, et al.
Publicado: (1995)

Management of the complications of BPH/BOO
por: Speakman, Mark J., et al.
Publicado: (2014)

“Boo-Khar”—India Fever
por: Condict, Alice B.
Publicado: (1889)

MicroBooNE and the $\nu_e$ Interpretation of the MiniBooNE Low-Energy Excess
por: Argüelles, C.A., et al.
Publicado: (2021)

Cerebral Oximetry in Preterm Infants–To Use or Not to Use, That Is the Question
por: Greisen, Gorm, et al.
Publicado: (2022)

Boo-boos as the building blocks of pain expression: An observational examination of parental responses to everyday pain in toddlers
por: Noel, Melanie, et al.
Publicado: (2018)

Non-Hormonal treatment of BPH/BOO
por: Osman, Nadir I., et al.
Publicado: (2014)

Correction: The Effect of Interpersonal Psychotherapy and other Psychodynamic Therapies versus ‘Treatment as Usual’ in Patients with Major Depressive Disorder
por: Jakobsen, Janus Christian, et al.
Publicado: (2011)

The Effect of Interpersonal Psychotherapy and other Psychodynamic Therapies versus ‘Treatment as Usual’ in Patients with Major Depressive Disorder
por: Jakobsen, Janus Christian, et al.
Publicado: (2011)

An Internet-based emotion regulation intervention versus no intervention for non-suicidal self-injury in adolescents: a statistical analysis plan for a feasibility randomised clinical trial
por: Olsen, Markus Harboe, et al.
Publicado: (2021)

Major mistakes and errors in the use of Trial Sequential Analysis in systematic reviews or meta-analyses – protocol for a systematic review
por: Riberholt, Christian Gunge, et al.
Publicado: (2022)

Modelling solar-like oscillations in $\eta$ Boo
por: Christensen-Dalsgaard, J, et al.
Publicado: (1994)

DSLs in Boo: domain-specific languages in .NET
por: Rahien, Ayende
Publicado: (2010)

Fermilab: MiniBooNE opens the box
Publicado: (2007)

Trial Sequential Analysis in systematic reviews with meta-analysis
por: Wetterslev, Jørn, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9v7rv355hbbth92jgkr719hrm5